Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Jun 7;11(21):3281-4.
doi: 10.3748/wjg.v11.i21.3281.

Tissue distribution and excretion of 125I-lidamycin in mice and rats

Affiliations

Tissue distribution and excretion of 125I-lidamycin in mice and rats

You-Ping Liu et al. World J Gastroenterol. .

Abstract

Aim: To investigate the tissue distribution, urinary and fecal excretions of (125)I-lidamycin ((125)I-C-1027) in mice and its biliary excretion in rats.

Methods: The total radioactivity assay (RA method) and the radioactivity assay after precipitation with 200 mL/L trichloroacetic acid (TCA-RA method) were used to determine the tissue distribution, and the urinary and fecal excretions of (125)I-C-1027 in mice and its biliary excretion in rats.

Results: Tissue concentrations reached the peak at the fifth minute after administration of (125)I-C-1027 to mice. The highest concentration was in kidney, and the lowest in brain at all test-time points. The organs of the concentrations of (125)I-C-1027 from high to low were kidney, lung, liver, stomach, spleen, uterus, ovary, intestine, muscle, heart, testis, fat, and brain in mice. The accumulative excretion amounts of 0-24 h, and 0-96 h after administration of (125)I-C-1027 were 68.36 and 71.64% in urine, and 2.60 and 3.21% in feces of mice, respectively, and the accumulative excretion amount of 0-24 h was 3.57% in bile in rats.

Conclusion: Our results reflect the characteristics of the tissue distribution, urinary and fecal excretions of (125)I-C-1027 in mice and the biliary excretion of (125)I-C-1027 and its metabolites in rats, and indicate that (125)I-C-1027 and its metabolites are mainly distributed in kidney, and excreted in urine.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Tissue distribution of radioactivity of 125I-C-1027 (50 ìg/kg) after i.v. injection to mice (n = 6). A: RA method; and B: TCA-RA method. Values were expressed as mean±SD.
Figure 2
Figure 2
Excretion curves after iv. injection of 125I-C-1027 (50 μg/kg) to mice by RA method (n = 6). A: excretion in urine; and B: excretion in feces. Values were expressed as mean±SD.
Figure 3
Figure 3
Bile excretion curve after i.v. injection of 125I-C-1027 (50 μg/kg) to rats by RA method (n = 5). Values were expressed as mean±SD.

Similar articles

Cited by

References

    1. Hu JL, Xue YC, Xie MY, Zhang R, Otani T, Minami Y, Yamada Y, Marunaka T. A new macromolecular antitumor antibiotic, C-1027. I. Discovery, taxonomy of producing organism, fermentation and biological activity. J Antibiot (Tokyo) 1988;41:1575–1579. - PubMed
    1. Otani T, Minami Y, Marunaka T, Zhang R, Xie MY. A new macromolecular antitumor antibiotic, C-1027. II. Isolation and physico-chemical properties. J Antibiot (Tokyo) 1988;41:1580–1585. - PubMed
    1. Zhen YS, Ming XY, Yu B, Otani T, Saito H, Yamada Y. A new macromolecular antitumor antibiotic, C-1027. III. Antitumor activity. J Antibiot (Tokyo) 1989;42:1294–1298. - PubMed
    1. Matsumoto T, Okuno Y, Sugiura Y. Specific interaction between a novel enediyne chromophore and apoprotein in macromolecular antitumor antibiotic C-1027. Biochem Biophys Res Commun. 1993;195:659–666. - PubMed
    1. Otani T. Conformation studies on and assessment by spectral analysis of the protein-chromophore interaction of the macromolecular antitumor antibiotic C-1027. J Antibiot (Tokyo) 1993;46:791–802. - PubMed

Publication types